AIM ImmunoTech Inc. · AMEX:AIM

Equels Thomas K bought 31,250 AIM ImmunoTech Inc. shares (Form 4)

Traded Oct 22, 2026 · Filed Oct 23, 2026

On Oct 22, 2026, Equels Thomas K (Director, CEO & President) bought 31,250 AIM ImmunoTech Inc. shares at US$0.16 for US$5,094, leaving 158,072 shares. Filed Oct 23, 2026 (Form 4).

Bought
31,250 shares
Price
US$0.16
Value
US$5,094
Holding after
158,072 shares
Trading plan
No
Role
Director, CEO & President

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 22, 2026Common StockBuy31,250US$0.16158,072Direct

Source

Download original · View original at SEC

Related